Steering Committee
The Steering Committee (SC) supports the German Biobank Node (GBN) in the implementation of the work programme and ensures that the biobanks of the German Biobank Alliance (GBA) cooperate effectively. The committee decides on all matters of the GBA and shapes the strategic orientation. In the past, the SC was composed of the heads of all partner biobanks of the GBA and the IT development centres, as well as Michael Hummel for GBN. Due to the strong growth in the number of biobank partners since 2019, the SC decided during its meeting in December 2020 to reduce the size of the committee and to elect a new one at the beginning of 2020.
Since January 2020, the Steering Committee has ten members: Prof. Dr. Michael Hummel, head of German Biobank Node (GBN), Prof. Dr. Thomas Illig, deputy spokesman of GBN, and the biobank representatives Dr. Heidi Altmann, Dr. Daniel Brucker, Prof. Dr. Roland Jahns and Dr. Romy Kirsten. Speakers for the work areas are Dr. Ronny Baber (Stakeholder Engagement and Communication), PD Dr. Michael Kiehntopf (Quality Management), PD Dr. Sara Nußbeck (Further Education) and Prof. Dr. Hans-Ulrich Prokosch (IT).
Scientific and Ethical Advisory Board
The Scientific and Ethical Advisory Board (SEAB) has an advisory role in accompanying the activities of GBN and GBA while supporting the Steering Committee in strategic issues for the implementation of the work programme. The SEAB is an independent committee comprising leading international scientists and experts who act independently of their organisational affiliation.
The Scientific Advisory Board is composed of representatives from various disciplines: Fay Betsou (quality management), Dominic Allen, Kristian Hveem (population-based biobanks), Johann Eder (IT), Kurt Zatloukal (clinical biobanks), Stefanie Houwaart (patient representation) and Jochen Taupitz (ethics).
© 2021 All rights reserved.
